✦ LIBER ✦

Expanding therapeutic targets in bladder cancer: the PI3K/Akt/mTOR pathway

✍ Scribed by Ching, Christina Barbara; Hansel, Donna Elizabeth

Book ID: 109885440
Publisher: Nature Publishing Group
Year: 2010
Tongue: English
Weight: 216 KB
Volume: 90
Category: Article
ISSN: 0023-6837
DOI: 10.1038/labinvest.2010.133

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Potential therapeutic targets for chordo

Potential therapeutic targets for chordoma: PI3K/AKT/TSC1/TSC2/mTOR pathway

✍ Presneau, N; Shalaby, A; Idowu, B; Gikas, P; Cannon, S R; Gout, I; Diss, T; Tira 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 538 KB

The PI3K/AKT/mTOR Signaling Pathway: Imp

The PI3K/AKT/mTOR Signaling Pathway: Implications in the Treatment of Breast Cancer

✍ Eleni Andreopoulou 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 278 KB

Drug discovery approaches targeting the

Drug discovery approaches targeting the PI3K/Akt pathway in cancer

✍ Garcia-Echeverria, C; Sellers, W R 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 343 KB

Targeting the Akt/mTOR pathway in Brca1-

Targeting the Akt/mTOR pathway in Brca1-deficient cancers

✍ Xiang, T; Jia, Y; Sherris, D; Li, S; Wang, H; Lu, D; Yang, Q 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 604 KB

Targeting the PI3K/AKT/mTOR Pathway in N

Targeting the PI3K/AKT/mTOR Pathway in Non-Hodgkin’s Lymphoma: Results, Biology, and Development Strategies

✍ Jonathan H. Schatz 📂 Article 📅 2011 🏛 Current Science Inc. 🌐 English ⚖ 262 KB

Therapeutic resistance resulting from mu

Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathways

✍ James A. McCubrey; Linda S. Steelman; C. Ruth Kempf; William H. Chappell; Stephe 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 869 KB

## Abstract Chemotherapy remains a commonly used therapeutic approach for many cancers. Indeed chemotherapy is relatively effective for treatment of certain cancers and it may be the only therapy (besides radiotherapy) that is appropriate for certain cancers. However, a common problem with chemothe